Athlete's Foot (Tinea Pedis) - Epidemiology Forecast to 2028

January 2019 | 50 pages | ID: AB2799DA451EN
DelveInsight

Abstracts

This report can be delivered to the clients within 5-7 Business Days

DelveInsight's 'Athlete's Foot (Tinea Pedis) - Epidemiology Forecast, 2028' report provides a comprehensive analysis of the Athlete's Foot (Tinea Pedis) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

MARKETS COVERED

• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Athlete's Foot (Tinea Pedis) Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Athlete's Foot (Tinea Pedis) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Athlete's Foot (Tinea Pedis) outlook. It also includes the explanation of changing trends of epidemiology outlining the Athlete's Foot (Tinea Pedis) scenario.
Athlete's Foot (Tinea Pedis) Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Athlete's Foot (Tinea Pedis) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

REPORT SCOPE

• The report covers detailed overview of Athlete's Foot (Tinea Pedis) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Athlete's Foot (Tinea Pedis) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

• 10 Year Forecast
• 7MM Coverage
• Total Cases in Athlete's Foot (Tinea Pedis)

Key assessments

• Patient Segmentation in Athlete's Foot (Tinea Pedis)
• Athlete's Foot (Tinea Pedis) Risk & Burden
• Factors driving growth in a specific Athlete's Foot (Tinea Pedis) patient population

Contents

1. REPORT INTRODUCTION

2. ATHLETE'S FOOT (TINEA PEDIS) EPIDEMIOLOGY OVERVIEW AT A GLANCE

2.1. Patient Share Distribution of Athlete's Foot (Tinea Pedis) in 2016
2.2. Patient Share Distribution of Athlete's Foot (Tinea Pedis) in 2028

3. DISEASE BACKGROUND AND OVERVIEW: ATHLETE'S FOOT (TINEA PEDIS)

3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment

4. EPIDEMIOLOGY AND PATIENT POPULATION

4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Athlete's Foot (Tinea Pedis) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Athlete's Foot (Tinea Pedis) in 7MM – By Countries

5. EPIDEMIOLOGY OF ATHLETE'S FOOT (TINEA PEDIS) BY COUNTRIES

5.1. United States
  5.1.1. Assumptions and Rationale
  5.1.2. Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis)
  5.1.3. Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis)
  5.1.4. Sex- Specific Cases of the Athlete's Foot (Tinea Pedis)
  5.1.5. Diagnosed Cases of the Athlete's Foot (Tinea Pedis)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
  5.4.1. Assumptions and Rationale
  5.4.2. Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis)
  5.4.3. Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis)
  5.4.4. Sex- Specific Cases of the Athlete's Foot (Tinea Pedis)
  5.4.5. Diagnosed Cases of the Athlete's Foot (Tinea Pedis)
5.5. France
  5.5.1. Assumptions and Rationale
  5.5.2. Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis)
  5.5.3. Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis)
  5.5.4. Sex- Specific Cases of the Athlete's Foot (Tinea Pedis)
  5.5.5. Diagnosed Cases of the Athlete's Foot (Tinea Pedis)
5.6. Italy
  5.6.1. Assumptions and Rationale
  5.6.2. Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis)
  5.6.3. Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis)
  5.6.4. Sex- Specific Cases of the Athlete's Foot (Tinea Pedis)
  5.6.5. Diagnosed Cases of the Athlete's Foot (Tinea Pedis)
5.7. Spain
  5.7.1. Assumptions and Rationale
  5.7.2. Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis)
  5.7.3. Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis)
  5.7.4. Sex- Specific Cases of the Athlete's Foot (Tinea Pedis)
  5.7.5. Diagnosed Cases of the Athlete's Foot (Tinea Pedis)
5.8. United Kingdom
  5.8.1. Assumptions and Rationale
  5.8.2. Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis)
  5.8.3. Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis)
  5.8.4. Sex- Specific Cases of the Athlete's Foot (Tinea Pedis)
  5.8.5. Diagnosed Cases of the Athlete's Foot (Tinea Pedis)
5.9. Japan
  5.9.1. Assumptions and Rationale
  5.9.2. Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis)
  5.9.3. Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis)
  5.9.4. Sex- Specific Cases of the Athlete's Foot (Tinea Pedis)
  5.9.5. Diagnosed Cases of the Athlete's Foot (Tinea Pedis)

6. UNMET NEEDS OF THE ATHLETE'S FOOT (TINEA PEDIS)

7. APPENDIX

8. REPORT METHODOLOGY

8.1. Sources

9. DELVEINSIGHT CAPABILITIES

10. DISCLAIMER

11. ABOUT DELVEINSIGHT

Indication Specific

List Of Tables

LIST OF TABLES

Table 1: Total Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in 7MM
Table 2: Total Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in United States (2016-2028)
Table 5: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in United States (2016-2028)
Table 6: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in Germany (2016-2028)
Table 9: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in Germany (2016-2028)
Table 10: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in France (2016-2028)
Table 12: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in France (2016-2028)
Table 13: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in France (2016-2028)
Table 14: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in Italy (2016-2028)
Table 17: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in Italy (2016-2028)
Table 18: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in Spain (2016-2028)
Table 21: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in Spain (2016-2028)
Table 22: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in UK (2016-2028)
Table 25: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in UK (2016-2028)
Table 26: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in Japan (2016-2028)
Table 29: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in Japan (2016-2028)
Table 30: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in Japan (2016-2028)

List Of Figures

LIST OF FIGURES

Figure 1: Total Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in United States (2016-2028)
Figure 5: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in United States (2016-2028)
Figure 6: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in Germany (2016-2028)
Figure 9: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in Germany (2016-2028)
Figure 10: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in France (2016-2028)
Figure 13: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in France (2016-2028)
Figure 14: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in Italy (2016-2028)
Figure 17: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in Italy (2016-2028)
Figure 18: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in Spain (2016-2028)
Figure 21: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in Spain (2016-2028)
Figure 22: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in UK (2016-2028)
Figure 25: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in UK (2016-2028)
Figure 26: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in Japan (2016-2028)
Figure 29: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in Japan (2016-2028)
Figure 30: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in Japan (2016-2028)